[go: up one dir, main page]

IL158860A0 - Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same - Google Patents

Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same

Info

Publication number
IL158860A0
IL158860A0 IL15886002A IL15886002A IL158860A0 IL 158860 A0 IL158860 A0 IL 158860A0 IL 15886002 A IL15886002 A IL 15886002A IL 15886002 A IL15886002 A IL 15886002A IL 158860 A0 IL158860 A0 IL 158860A0
Authority
IL
Israel
Prior art keywords
phor
cancer
useful
detection
treatment
Prior art date
Application number
IL15886002A
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/001,469 external-priority patent/US7208280B2/en
Priority claimed from US10/017,066 external-priority patent/US6838258B2/en
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of IL158860A0 publication Critical patent/IL158860A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15886002A 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same IL158860A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29111801P 2001-05-15 2001-05-15
US10/001,469 US7208280B2 (en) 1999-10-05 2001-10-31 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US10/017,066 US6838258B2 (en) 1999-10-05 2001-12-14 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
PCT/US2002/015520 WO2002092842A2 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer

Publications (1)

Publication Number Publication Date
IL158860A0 true IL158860A0 (en) 2004-05-12

Family

ID=38616826

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15886002A IL158860A0 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same

Country Status (6)

Country Link
EP (1) EP1539805A4 (en)
JP (1) JP2005512509A (en)
AU (2) AU2002309873B2 (en)
CA (1) CA2447564A1 (en)
IL (1) IL158860A0 (en)
WO (1) WO2002092842A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
EP1596871A4 (en) * 2003-02-28 2006-08-23 Drew M Pardoll REGULATION BY LYMPHOCYTES T
JP5122592B2 (en) * 2010-01-04 2013-01-16 アジェンシス，インコーポレイテッド Nucleic acids and corresponding proteins referred to as 24P4C12 useful in the treatment and detection of cancer
US10722563B2 (en) * 2012-09-20 2020-07-28 Shenzhen Innovation Immunotechnology Co., Ltd. Prostate-specific tumor antigens and uses thereof
CN111549140B (en) * 2020-06-08 2023-08-08 重庆医科大学附属第一医院 Kit for detecting methylation of lung cancer related genes C2orf40, FIBUN and GRP and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033602A1 (en) * 1996-03-11 1997-09-18 Cytel Corporation Peptides with increased binding affinity for hla molecules
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
AU3215800A (en) * 1999-01-27 2000-08-18 Epimmune, Inc. Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
JP4272376B2 (en) * 1999-10-05 2009-06-03 アジェンシス，インコーポレイテッド G protein-coupled receptors up-regulated in prostate cancer and uses thereof
WO2001027158A2 (en) * 1999-10-08 2001-04-19 Digiscents Olfactory receptor sequences
US20030088059A1 (en) * 2000-03-13 2003-05-08 Sergey Zozulya Human olfactory receptors and genes encoding same
EP1311673A2 (en) * 2000-03-27 2003-05-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001074904A2 (en) * 2000-03-31 2001-10-11 Curagen Corporation G-protein coupled receptors and nucleic acids encoding same
US20030022237A1 (en) * 2000-09-27 2003-01-30 Feder John N. Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
AU2008200363A1 (en) 2008-02-21
EP1539805A4 (en) 2005-11-16
WO2002092842A3 (en) 2005-04-21
CA2447564A1 (en) 2002-11-21
AU2008200363B2 (en) 2010-08-12
EP1539805A2 (en) 2005-06-15
WO2002092842A2 (en) 2002-11-21
AU2008200363A8 (en) 2008-03-13
JP2005512509A (en) 2005-05-12
AU2002309873B2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
AU2002318112B2 (en) Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP1576104A4 (en) Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
WO2003087306A8 (en) Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
HK1152714A1 (en) Coded-controlled nucleic acids and related proteins for the treatment and diagnosis of cancer
IL219310A (en) Anti-mirna nucleic acid molecules and pharmaceutical compositions comprising them
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
EP1517606A4 (en) Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
EP1622571A4 (en) Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
EP1372719A4 (en) Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
EP1590437A4 (en) Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
IL158860A0 (en) Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
AU2001285018A1 (en) Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
AU2002258785A1 (en) Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
GB0118995D0 (en) Detection of mutations in nucleic acids
IL170080A (en) Nucleic acid and protein named 158p1d7 and pharmaceutical compositions containing the same
EP1399174A4 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
EP1578980A4 (en) Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
IL160651A0 (en) Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
AU2001286541A1 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
AU2002305171A1 (en) Nucleic acid sequences useful in the detection and treatment of various cancers
AU2002305170A1 (en) Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
AU2012244341A1 (en) Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer
ZA200208348B (en) Nucleic acid binding peptides and the use of such peptides in pharmaceutical preparations.